ProShare Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $734K | Sell |
|
|||||
|
2025
Q1 | $594K | Sell |
|
|||||
|
2024
Q4 | $763K | Buy |
|
|||||
|
2024
Q3 | $499K | Buy |
|
|||||
|
2024
Q2 | $433K | Sell |
|
|||||
|
2024
Q1 | $621K | Buy |
|
|||||
|
2023
Q4 | $956K | Buy |
|
|||||
|
2023
Q3 | $551K | Buy |
|
|||||
|
2023
Q2 | $630K | Buy |
|
|||||
|
2023
Q1 | $478K | Sell |
|
|||||
|
2022
Q4 | $459K | Buy |
|
|||||
|
2022
Q3 | $440K | Sell |
|
|||||
|
2022
Q2 | $395K | Sell |
|
|||||
|
2022
Q1 | $1.01M | Sell |
|
|||||
|
2021
Q4 | $1.21M | Sell |
|
|||||
|
2021
Q3 | $871K | Sell |
|
|||||
|
2021
Q2 | $1.56M | Buy |
|
|||||
|
2021
Q1 | $628K | Sell |
|
|||||
|
2020
Q4 | $1.42M | Sell |
|
|||||
|
2020
Q3 | $1.13M | Buy |
|
|||||
|
2020
Q2 | $1.3M | Sell |
|
|||||
|
2020
Q1 | $1.26M | Sell |
|
|||||
|
2019
Q4 | $2.19M | Sell |
|
|||||
|
2019
Q3 | $1.93M | Sell |
|
|||||
|
2019
Q2 | $1.52M | Sell |
|
|||||
|
2019
Q1 | $1.76M | Buy |
|
|||||
|
2018
Q4 | $994K | Sell |
|
|||||
|
2018
Q3 | $1.38M | Sell |
|
|||||
|
2018
Q2 | $1.03M | Buy |
|
|||||
|
2018
Q1 | $1.35M | Sell |
|
|||||
|
2017
Q4 | $2.1M | Sell |
|
|||||
|
2017
Q3 | $2.68M | Buy |
|
|||||
|
2017
Q2 | $1.8M | Sell |
|
|||||
|
2017
Q1 | $2.3M | Sell |
|
|||||
|
2016
Q4 | $2.35M | Buy |
|
|||||
|
2016
Q3 | $2.5M | Sell |
|
|||||
|
2016
Q2 | $2.83M | Sell |
|
|||||
|
2016
Q1 | $2.67M | Sell |
|
|||||
|
2015
Q4 | $3.41M | Buy |
|
|||||
|
2015
Q3 | $2.89M | Sell |
|
|||||
|
2015
Q2 | $3.78M | Sell |
|
|||||
|
2015
Q1 | $3.13M | Buy |
|
|||||
|
2014
Q4 | $2.63M | Buy |
|
|||||
|
2014
Q3 | $2.04M | Sell |
|
|||||
|
2014
Q2 | $2.22M | Sell |
|
|||||
|
2014
Q1 | $3.43M | Buy |
|
|||||
|
2013
Q4 | $1.13M | Sell |
|
|||||
|
2013
Q3 | $2.07M | Buy |
|
|||||
|
2013
Q2 | $306K | Buy |
|